🇺🇸 FDA
Pipeline program

Dexmedetomidine

2022LY0416

Unknown small_molecule completed

Quick answer

Dexmedetomidine for Lung Cancer is a Unknown program (small_molecule) at Shiyou Wei with 1 ClinicalTrials.gov record(s).

Program details

Company
Shiyou Wei
Indication
Lung Cancer
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials